HORSHAM, Pa., Jan. 28, 2016 -- Symphony Health Solutions, a provider of high-value market research, analytics and technology solutions for life science manufacturers, researchers, payers and providers, today announced that multiple members of the company’s consulting practice have been selected as presenters for the 2016 Pharmaceutical Management Science Association (PMSA) Annual Conference in Las Vegas this April. The PMSA Annual Conference is a forum for life science industry experts to network, exchange best practices, and learn about emerging trends in analytics for the pharmaceutical industry.
Symphony’s Ewa Kleczyk, PhD, Executive Director of Consulting and Services, and Derek Evans, Sr. Vice President and Commercial Effectiveness Practice Head, will present “Leveraging Secondary Physician and Patient Level Data to Predict Physician Attitudinal Segment Assignments”. Their presentation will provide an overview of Symphony’s proprietary Hybrid Segmentation solution which allows the projection of physician segments to a larger physician list by leveraging the attitudinal information, robustness of secondary data, and proprietary physician level prescribing propensities. Through use of a case study in the Oncology area, the presentation will review methodology steps needed to ensure that the “Hybrid” approach yields high accuracy prediction and consistency in assigning physicians into intended segments.
Christopher Casten, Managed Markets Principal at Symphony, will present “Do You Really Need to Contract with a Payer?” Payer contracting can be the most significant spend that manufacturers believe will drive brand access. But the lack of insight into the patient’s ability to ultimately receive the brand, even without a manufacturer/payer contract, can have significant financial impact on a brand’s revenue. This presentation will review an actual, historical study done in conjunction with a major, US biologic manufacturer to show the impact of benefit design and payer contracting on patients’ ability to fill their prescriptions.
In addition to the presentations, Symphony will exhibit several posters in the conference’s Poster Sessions:
- Alternative Methodologies of Measuring Medication Usage Amongst Chronically Ill patients with Idiosyncratic Treatment Plan
- Measuring Media Exposure with Health Behavior and Patient Pathing Metrics
- Launching an Oncology Brand – Get it Right Using Big Data
Poster authors and representatives from Symphony Health Solutions will be present throughout the conference to share insights into how data and analytics from Symphony’s IDV® (Integrated Dataverse) can answer key questions and facilitate critical commercial processes within sales, marketing, and managed markets.
Symphony Health Solutions is proud to continue a long-standing relationship with PMSA. During the 2015 Annual Conference, Michael Venters, Product Management Director at Symphony, delivered a presentation on Prescription Buy-Down Program Effectiveness. PMSA and Symphony also partnered throughout the summer of 2015 to offer a four-installment Data Training Webinar Series presented by Symphony Health’s Laura Jirele.
PMSA, focused this year on Game-Changing Analytics: The Odds Are in Your Favor, will be held April 17-20, 2016 at Planet Hollywood Hotel in Las Vegas, Nevada. For more information or to register for the PMSA 2016 Annual Conference, visit the website.
For more information about Symphony Health Solutions, visit www.symphonyhealth.com.
About Symphony Health Solutions
Symphony Health Solutions is a leading provider of high-value data, analytics, technology solutions and actionable insights for healthcare and life sciences manufacturers, payers and providers. The company helps clients drive revenue growth and commercial effectiveness, while adapting to the transformation of the healthcare ecosystem, by integrating a broad set of patient, prescriber, payer and clinical data together with primary and secondary health research, analytics and consulting. Symphony delivers a comprehensive perspective on the real dynamics that drive business in the healthcare and life sciences markets. For more information, visit www.symphonyhealth.com.
For media information, please contact: Heather Varela, Symphony Health Solutions [email protected] +1 602.463.7838


Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
BHP Q4 Iron Ore Output Rebounds as Copper Prices Boost Revenue
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 



